CRISPR target prediction remains blunt tool for clinical applications
Nat Biotechnol
.
2019 Mar;37(3):204-205.
doi: 10.1038/s41587-019-0057-7.
Author
John Hodgson
1
Affiliation
1
, Cambridge, UK.
PMID:
30833770
DOI:
10.1038/s41587-019-0057-7
No abstract available
Publication types
News
MeSH terms
Biomedical Research / trends*
CRISPR-Cas Systems / genetics*
Gene Editing / trends*
Humans